Finally, aptamers targeting lncRNA beta‐secretase 1 (BACE1)‐antisense RNA (BACE1‐AS) demonstrated efficacy in reducing its expression and inhibiting the transcription of BACE1, a key enzyme in AD pathogenesis.296. Here, BACE1 is linked to Alzheimer disease.